Healthcare Professional Check

This website is intended for diabetes healthcare professionals. Click one of the options below to access the content.

You are here

Efficacy and Safety for Diabetes Specialists

for Diabetes Specialists

The purpose of this course is to learn how the efficacy and safety of basal insulin–glucagon-like peptide-1 (GLP-1) receptor agonist combination therapy surpasses that of the individual components. Participants will learn how to identify patients who are most likely to benefit from this combination. Practical considerations will be discussed, including tips on how to best manage patients during treatment with basal insulin–GLP-1 receptor agonist combination therapy.

Course contents

  • Webcast

    Advantages of basal insulin GLP-1 RA combination 

    • Intensified treatment goals/options
    • Data from phase 3 clinical trials
    • Convenience of a single injection
    • Cost-effectiveness
    • Upcoming trials and potential use of fixed-ratio combination in T1D
  • Roundtable

    Improved safety profile over components

    • Lower risk of hypoglycaemia and less weight gain than insulin component
    • Fewer gastrointestinal side effects than GLP-1 RA component
  • Selected article

    IDegLira Versus Alternative Intensification Strategies in Patients with Type 2 Diabetes Inadequately Controlled on Basal Insulin Therapy

  • Selected article

    IDegLira Both Fasting and Postprandial Glucose Control as Demonstrated Using Continuous Glucose Monitoring and a Standardized Meal Test

  • Selected article

    Type 2 Diabetes Patients Reach Target Glycemic Control Faster Using IDEGLira than Either Insulin Degludec or Liraglutide Given Alone

Courses are now online!

Register for the Insulin Educational program and start any available content whenever you want. You can sign up to the E-alert list to be notified when new courses or course modules are uploaded.


Search this site

Search form


 

Developed by Elsevier B.V., supported by an unrestricted educational grant from Novo Nordisk